# A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse

> **NCT01846481** · PHASE2 · COMPLETED · sponsor: **Indivior Inc.** · enrollment: 40 (actual)

## Conditions studied

- Opioid Dependence
- Opioid Related Disorders
- Cocaine Dependence

## Interventions

- **DRUG:** RBP-8000 100 mg
- **DRUG:** Placebo
- **DRUG:** Cocaine
- **DRUG:** RBP-8000 200 mg

## Key facts

- **NCT ID:** NCT01846481
- **Lead sponsor:** Indivior Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01846481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01846481, "A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT01846481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*